← FDA DRUG APPROVALS

FDA ANDA · ANDA204899

LEVOFLOXACIN

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA204899
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-08
LATEST ACTION
2017-12-08
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

LEVOFLOXACINDiscontinued
LEVOFLOXACIN 0.5% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2017-12-08UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →